Close menu
Brain & Behavior
Grants & Prizes
Home
Research
Illness
Addiction
Anxiety Disorders
Attention-Deficit Hyperactivity Disorder (ADHD)
Autism Spectrum Disorder (ASD)
Bipolar Disorder
Borderline Personality Disorder (BPD)
Depression
Eating Disorders
Mental Illness (General)
Obsessive-Compulsive Disorder (OCD)
Post-Traumatic Stress Disorder (PTSD)
Schizophrenia
Suicide Prevention
Other Brain-Related Illnesses
Category
Basic Research
New Technologies
Early Intervention/ Diagnostic Tools
Next Generation Therapies
Blog
Get Involved
Give
Donate Today
Make a Memorial/Tribute Gift
Create an Event/Memorial Page
Find an Event/Memorial Page
Make a Stock/Securities Gift/IRA Charitable Rollover Gift
Donate Cryptocurrency
Get Involved
Other Giving Opportunities
$1 Million Challenge Match
Planned Giving
Research Partners
Donor Advised Funds
Workplace Giving
Team Up for Research!
Sponsorship Opportunities
Watch
Healthy Minds TV
Meet the Scientist Webinars
Videos
Connect
Ask the Expert
Join Us
Home
Grants
Grant FAQs
BBRF Young Investigator Grants
BBRF Independent Investigator Grants
BBRF Distinguished Investigator Grants
Prizes & Awards
Klerman & Freedman Prizes
Outstanding Achievement Prizes
Lieber Prize for Schizophrenia Research
Maltz Prize for Schizophrenia Research
Colvin Prize for Mood Disorders Research
Ruane Prize for Child and Adolescent Psychiatric Research
Goldman-Rakic Prize for Cognitive Neuroscience Research
The Pardes Humanitarian Prize
Productive Lives Awards
Blog
About Us
Who We Are
Our Impact
FAQs
Media Center
News
Press Releases
Opinion Pieces
In the News
Multimedia Library
Media Kit
Events & Webinars
Team Up for Research! Events
Healthy Minds TV
Contact
Email Signup
Open Menu

Menu

Rapid-Acting Treatments for Pediatric Depression and Suicidality: Where are We Now?

Tuesday, March 8, 2022, 2:00 pm EST
Meet the Scientist - March 2022

The field of rapid-acting treatments for depression and suicidality has grown considerably for adult treatment-resistant depression over the past 20 years. Despite increasing rates of pediatric depression and anxiety, and rising youth suicide rates, the evidence base for rapid-acting treatments for children and adolescents is only starting to form. In this webinar Dr. Dwyer will discuss the current data available for rapid-acting treatments in pediatric patients. She will identify the key questions that require more research and highlight ways that her team is working to address these knowledge gaps.

Watch webinar recording:

Please use #BBRFWebinar when sharing or posting about our Meet the Scientist Webinars on social media.

Sign up for other upcoming webinars.

View past webinar recordings.

Presentation

Download Slide Presentation
Presented by 
Jennifer Dwyer, M.D., Ph.D.
Jennifer Dwyer, M.D., Ph.D.

Assistant Professor; Co-Director and Co-Founder of the Pediatric Depression Clinic

Yale School of Medicine

2020 Young Investigator Grant

Dr. Dwyer completed her MD and PhD (Pharmacology) at the Univ. of California, Irvine, where she studied the development of the dopamine system in adolescence. She works clinically with children and adults, with a broad interest in how the brain and mind develop over time. She studies treatment-refractory adolescent depression, and hopes to better predict who will respond to different types of treatments, ranging from intensive psychotherapies to novel pharmacotherapeutics (e.g. ketamine).
Moderated by 
Dr. Jeffrey Borenstein, President and CEO of the Brain & Behavior Research Foundation
Read Full Bio
Jeffrey Borenstein, M.D.
Brain & Behavior Research Foundation

President and CEO

Jeffrey Borenstein, M.D., serves as the President & CEO of the Brain & Behavior Research Foundation, the largest private funder of mental health research grants. Dr. Borenstein developed the Emmy-nominated public television program “Healthy Minds,” and serves as host and executive producer of the series. The program, broadcast nationwide, is available online, and focuses on topics in psychiatry in order to educate the public, reduce stigma and offer a message of hope. Dr. Borenstein also serves as Editor-in-Chief of Psychiatric News, the newspaper of the American Psychiatric Association.

Dr. Borenstein is a Fellow of the New York Academy of Medicine and serves as the Chair of the Section of Psychiatry at the Academy. He also has served as the President of the New York State Psychiatric Association. Dr. Borenstein earned his undergraduate degree at Harvard and his medical degree at New York University.